INTERNATIONAL JOURNAL OF CLINICAL RESEARCH AND MEDICAL SCIENCES

Pharmacognosy-to-Candidate: Protease-Directed Prioritization of Plant-Derived Glycosides via Minimal Semi-Synthetic Optimization

1.Rowan University

Published in issue

October 2026

Volume / Issue

Vol. 1 No. 2

Access

Open access

View PDF

The article details presented on this page reflect the published version of record. Readers may access the full-text PDF, review the citation information, and export the reference in supported citation formats.

Abstract

This study establishes an integrated pharmaceutical discovery pipeline from medicinal plant profiling to preclinical candidate identification, focusing on SARS-CoV-2 main protease (Mpro) inhibition. Comprehensive LC-ESI-TOF-MS/MS analysis of Cynanchum acutum L. identified 46 metabolites, with quercetin-3-O-β-galactoside (Q) characterized as the dominant flavonoid glycoside (3.71 mg/g crude extract) through validated HPTLC/HPLC methods. Strategic semi-synthetic optimization via selective O-alkylation generated two analogues (Q1: 7-benzyl; Q2: 7-bromoethyl) to enhance hydrophobicity and membrane permeability. Antiviral evaluation in Vero-E6 cells demonstrated significant SARS-CoV-2 inhibition, with the crude extract (IC₅₀ = 23.99 μg/mL, SI = 13.66) and benzyl derivative Q1 (IC₅₀ = 29.21 μg/mL, SI = 11.06) showing superior potency over the parent compound Q (IC₅₀ = 59.73 μg/mL, SI = 6.16). Molecular docking revealed preferential Mpro binding for Q1 (-8.34 kcal/mol) through conserved catalytic-site interactions with Cys145 and His41. The workflow exemplifies a minimal-chemistry approach from natural product hit to preclinical candidate, validated through orthogonal analytics and structure-activity relationships.
Keywords:Antiviral agentsNatural ProductsMedicinal plantsMolecular dockingDrug DiscoverySARS-CoV-2

Cite this Article

Use the following citation when referencing this publication in academic or professional work.

R. Singh, "Pharmacognosy-to-Candidate: Protease-Directed Prioritization of Plant-Derived Glycosides via Minimal Semi-Synthetic Optimization", Int. J. Clin. Res. Med. Sci., vol. 1, no. 2, Oct. 2026, doi: https://doi.org/10.67231/rxn6m387.

DOWNLOAD CITATION

Pharmacognosy-to-Candidate: Protease-Directed Prioritization of Plant-Derived Glycosides via Minimal Semi-Synthetic Optimization | International Journal of Clinical Research and Medical Sciences